Annual CFF
$5.93 M
+$5.75 M+3139.89%
December 31, 2023
Summary
- As of February 22, 2025, PYXS annual cash flow from financing activities is $5.93 million, with the most recent change of +$5.75 million (+3139.89%) on December 31, 2023.
- During the last 3 years, PYXS annual CFF has risen by +$5.89 million (+16840.00%).
- PYXS annual CFF is now -98.05% below its all-time high of $304.04 million, reached on December 31, 2021.
Performance
PYXS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$1.66 M
+$1.54 M+1404.55%
September 30, 2024
Summary
- As of February 22, 2025, PYXS quarterly cash flow from financing activities is $1.66 million, with the most recent change of +$1.54 million (+1404.55%) on September 30, 2024.
- Over the past year, PYXS quarterly CFF has increased by +$1.83 million (+1067.84%).
- PYXS quarterly CFF is now -98.93% below its all-time high of $154.90 million, reached on December 31, 2021.
Performance
PYXS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$59.25 M
+$1.83 M+3.18%
September 30, 2024
Summary
- As of February 22, 2025, PYXS TTM cash flow from financing activities is $59.25 million, with the most recent change of +$1.83 million (+3.18%) on September 30, 2024.
- Over the past year, PYXS TTM CFF has increased by +$53.30 million (+895.15%).
- PYXS TTM CFF is now -80.51% below its all-time high of $304.04 million, reached on December 31, 2021.
Performance
PYXS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PYXS Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3139.9% | +1067.8% | +895.1% |
| 3 y3 years | +10000.0% | -73.0% | +866.4% |
| 5 y5 years | -73.0% | -73.0% | +866.4% |
PYXS Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -98.0% | +3139.9% | -98.9% | +1067.8% | -80.5% | >+9999.0% |
| 5 y | 5-year | -98.0% | >+9999.0% | -98.9% | +196.9% | -80.5% | >+9999.0% |
| alltime | all time | -98.0% | >+9999.0% | -98.9% | +196.9% | -80.5% | >+9999.0% |
Pyxis Oncology Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.66 M(+1404.5%) | $59.25 M(+3.2%) |
| Jun 2024 | - | $110.00 K(-99.8%) | $57.42 M(-9.5%) |
| Mar 2024 | - | $57.51 M(<-9900.0%) | $63.44 M(+970.0%) |
| Dec 2023 | $5.93 M(+3139.9%) | -$25.00 K(-85.4%) | $5.93 M(-0.4%) |
| Sep 2023 | - | -$171.00 K(-102.8%) | $5.95 M(-2.9%) |
| Jun 2023 | - | $6.13 M(>+9900.0%) | $6.13 M(>+9900.0%) |
| Mar 2023 | - | $0.00(0.0%) | $7000.00(-96.2%) |
| Dec 2022 | $183.00 K | $0.00(-100.0%) | $183.00 K(-99.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $6000.00(+500.0%) | $155.08 M(+1.1%) |
| Jun 2022 | - | $1000.00(-99.4%) | $153.37 M(+0.4%) |
| Mar 2022 | - | $176.00 K(-99.9%) | $152.69 M(-49.8%) |
| Dec 2021 | $304.04 M(>+9900.0%) | $154.90 M(-9169.1%) | $304.04 M(+103.9%) |
| Sep 2021 | - | -$1.71 M(+150.4%) | $149.14 M(-1.1%) |
| Jun 2021 | - | -$682.00 K(-100.5%) | $150.85 M(-0.5%) |
| Mar 2021 | - | $151.53 M | $151.53 M |
| Dec 2020 | $35.00 K(-99.8%) | - | - |
| Dec 2019 | $21.95 M | - | - |
FAQ
- What is Pyxis Oncology annual cash flow from financing activities?
- What is the all time high annual CFF for Pyxis Oncology?
- What is Pyxis Oncology annual CFF year-on-year change?
- What is Pyxis Oncology quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Pyxis Oncology?
- What is Pyxis Oncology quarterly CFF year-on-year change?
- What is Pyxis Oncology TTM cash flow from financing activities?
- What is the all time high TTM CFF for Pyxis Oncology?
- What is Pyxis Oncology TTM CFF year-on-year change?
What is Pyxis Oncology annual cash flow from financing activities?
The current annual CFF of PYXS is $5.93 M
What is the all time high annual CFF for Pyxis Oncology?
Pyxis Oncology all-time high annual cash flow from financing activities is $304.04 M
What is Pyxis Oncology annual CFF year-on-year change?
Over the past year, PYXS annual cash flow from financing activities has changed by +$5.75 M (+3139.89%)
What is Pyxis Oncology quarterly cash flow from financing activities?
The current quarterly CFF of PYXS is $1.66 M
What is the all time high quarterly CFF for Pyxis Oncology?
Pyxis Oncology all-time high quarterly cash flow from financing activities is $154.90 M
What is Pyxis Oncology quarterly CFF year-on-year change?
Over the past year, PYXS quarterly cash flow from financing activities has changed by +$1.83 M (+1067.84%)
What is Pyxis Oncology TTM cash flow from financing activities?
The current TTM CFF of PYXS is $59.25 M
What is the all time high TTM CFF for Pyxis Oncology?
Pyxis Oncology all-time high TTM cash flow from financing activities is $304.04 M
What is Pyxis Oncology TTM CFF year-on-year change?
Over the past year, PYXS TTM cash flow from financing activities has changed by +$53.30 M (+895.15%)